dc.contributor.author |
Florentini, E.A. |
|
dc.contributor.author |
Angulo, N. |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.contributor.author |
Alcántara, R. |
|
dc.contributor.author |
Roncal, E. |
|
dc.contributor.author |
Antiparra, R. |
|
dc.contributor.author |
Toscano, E. |
|
dc.contributor.author |
Vallejos, K. |
|
dc.contributor.author |
Kirwan, D. |
|
dc.contributor.author |
Zimic-Peralta, Mirko Juan |
|
dc.contributor.author |
Sheen Cortavarria, Patricia |
|
dc.date.accessioned |
2020-12-14T16:06:23Z |
|
dc.date.available |
2020-12-14T16:06:23Z |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/8709 |
|
dc.description.abstract |
Pyrazinamide (PZA) susceptibility testing in Mycobacterium tuberculosis (Mtb) is a current area of development and PZA-resistant strains are increasingly prevalent. Previous studies have demonstrated that the detection of pyrazinoic acid (POA), the metabolite produced by the deamidation of PZA, is a good predictor for PZA resistance since a resistant strain would not convert PZA into POA at a critical required rate, whereas a susceptible strain will do, expelling POA to the extracellular environment at a certain rate, and allowing for quantification of this accumulated analyte. In order to quantify POA, an indirect competitive ELISA (icELISA) test using hyperimmune polyclonal rabbit serum against POA was developed: For this purpose, pure POA was first covalently linked to the highly immunogenic Keyhole Limpet Hemocyanine, and inoculated in rabbits. A construct made of bovine serum albumin (BSA) linked to pure POA and fixed at the bottom of wells was used as a competitor against spiked samples and liquid Mtb culture supernatants. When spiked samples (commercial POA alone) were analyzed, the half maximal inhibitory concentration (IC50) was 1.16 mg/ mL, the limit of detection 200 μg/mL and the assay was specific (it did not detect PZA, IC50 > 20 mg/mL). However, culture supernatants (7H9-OADC-PANTA medium) disrupted the competition and a proper icELISA curve was not obtainable. We consider that, although we have shown that it is feasible to induce antibodies against POA, matrix effects could damage its analytical usefulness; multiple, upcoming ways to solve this obstacle are suggested. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Public Library of Science |
|
dc.relation.ispartofseries |
PLoS ONE |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Enzyme-linked immunoassays |
en_US |
dc.subject |
Mycobacterium tuberculosis |
en_US |
dc.subject |
Antigens |
en_US |
dc.subject |
Antibodies |
en_US |
dc.subject |
Immunologic adjuvants |
en_US |
dc.subject |
Chemical synthesis |
en_US |
dc.subject |
Tuberculosis |
en_US |
dc.subject |
Mutation |
en_US |
dc.title |
Immunological detection of pyrazine-2- carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1371/journal.pone.0241600 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.07 |
|
dc.relation.issn |
1932-6203 |
|